David W Henson

Title: David W. Henson: Innovator in Pharmaceutical Chemistry

Introduction

David W. Henson is a notable inventor based in LaSalle, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on piperazine compounds. His research focuses on developing compounds with potential therapeutic applications.

Latest Patents

David W. Henson holds 1 patent for his invention titled "Piperazino-anilido compounds." This patent discloses novel 1,4-disubstituted piperazine compounds and pharmaceutical compositions that incorporate these compounds. The compounds are designed to be administered orally, parenterally, or rectally, using pharmaceutically acceptable carriers. Notably, these compounds exhibit coronary vasodilating properties, which could have important implications for cardiovascular health. The patent also details processes for preparing these compounds and introduces novel intermediate compounds used in these processes.

Career Highlights

David W. Henson is associated with Delmar Chemicals Inc., where he applies his expertise in pharmaceutical development. His work at the company has contributed to advancements in the field, particularly in the synthesis of innovative chemical compounds.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including Ctirad Podesva and William T. Scott. These collaborations have fostered a productive environment for research and development in pharmaceutical chemistry.

Conclusion

David W. Henson's contributions to the field of pharmaceutical chemistry, particularly through his innovative piperazine compounds, highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.